Title of article
Risk of Mortality due to Sudden Hyperglycemia in COVID-19 Patients
Author/Authors
Awad, W Department of Biochemistry - College of Medicine - University of Kerbala - Kerbala, Iraq , Kadhim, H.M Department of Physiology and Medical Physics - College of Medicine - University of Al-Ameed - Kerbala, Iraq , Hassan, D.M Department of Biochemistry - Health and Medical Technical College - Women University of Al-Zahraa - Kerbala, Iraq , Al-Yassiry, K.A.R Department of Pharmacology - College of Medicine - University of Kerbala - Kerbala, Iraq
Pages
4
From page
199
To page
202
Abstract
Aims One of the most dangerous complications of COVID-19 is sudden hyperglycemia that
may carry a high incidence of the death rate. This study aimed to evaluate the relationship
between death rate and hyperglycemia caused by COVID-19 infection in non-diabetic
patients.
Materials & Methods In this study, 296 patients were selected randomly, 57 patients
complaining of sudden hyperglycemia (>400 mg/dl) one week after the high fever subsided;
the others did not show such complain. Statistical analysis was done to evaluate the relative
risk of hyperglycemia upon the incidence of mortality rate between two groups.
Findings The X2 value was 20.5959 for all, and the p-value was not significant except for
COVID-19 with hyperglycemia that showed a highly significant mortality rate (X2=15.9,
p<0.001).
Conclusion Hyperglycemia should be monitored even after regression of COVID-19
symptoms, and insulin therapy must be considered to minimize the risk of death.
Keywords
COVID-19 , Hyperglycemia , Mortality Rate
Journal title
Iranian Journal of War and Public Health
Serial Year
2021
Record number
2727822
Link To Document